This is a news story, published by Sky News, that relates primarily to the University of Southern California news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
weekly alcohol cravings. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest alcohol consumption news, Ozempic news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
fewer heavy drinking daysSky News
•Health
Health
76% Informative
Scientists at the University of Southern California monitored 48 people with alcohol use disorder.
Ozempic and other semaglutide drugs reduce cravings for alcohol.
The drugs, best known for their use in weight loss and diabetes treatment, also appeared to reduce how many cigarettes people smoked.
The injections were more effective than existing medications used to treat drinking problems.
VR Score
74
Informative language
73
Neutral language
53
Article tone
semi-formal
Language
English
Language complexity
58
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links